Jury Awards $500,000 in Risperdal Trial
A Philadelphia jury awarded $500,000 in compensatory damages to a young man who claimed he grew female-like breasts after taking the antipsychotic drug Risperdal. The jury deliberated six hours before finding the manufacturers of Risperdal, Janssen Pharmaceuticals (a division of Johnson & Johnson), failed to warn health care providers and patients of a condition called […]
News: Trials Begin October 2015
Sheller, P.C. law firm Risperdal cases continue, with trials beginning October, 2015. From the daily newspaper The Legal Intelligencer: “A second wave of trials in the Risperdal mass tort has been scheduled for October, and several more cases are gearing up for trials in the spring. Two trials against Janssen Pharmaceuticals, the maker of the […]
Risperdal News: Sheller Quoted in Toronto Star
Stephen Sheller was quoted in a July 31, 2015 article discussing Risperdal research that was “manipulated by a drug company and understated the risks of a powerful antipsychotic used to treat kids with behavioural problems.” In the news story, pediatrician Denis Daneman says there was no intent on his part to exclude “significant results” from […]
J&J Loses Trial Over Risperdal and Male Breast
The Wall Street Journal Pharmalot Blog 2015-02-24 In a setback to Johnson & Johnson, a Philadelphia jury decided the health care giant must pay $2.5 million in damages for failing to warn that its Risperdal antipsychotic could cause gynecomastia, which is abnormal development of breasts in males. The lawsuit was brought by the family of […]
$2.5 Million Verdict
A Philadelphia jury awarded $2.5 million to a twenty year old man whose family claimed he developed female-like breasts (gynecomastia) from taking the antipsychotic drug Risperdal for five years from ages eight to thirteen. Stephen A. Sheller, attorney for the family: “We are encouraged to see this day come, after ten years of our pursuing […]
Sheller Six Risperdal Settlements, Hundreds More Boys Represented
Sheller Spars With FDA
Lawyer Spars With FDA Over J&J Risperdal Court Documents by Ed Silverman, Pharmalot In an unusual tactic, an attorney is prodding the FDA to seek documents that purportedly detail side effects caused by the Risperdal antipsychotic, but cannot be released publicly due to a court order. The documents were sealed by a Philadelphia judge as […]
Sheller on Lawyer Spars With FDA Over J&J Risperdal Court Documents
Pharmalot.com, Pharmaceutical Industry News 2013-07-11 In an unusual tactic, an attorney is prodding the FDA to seek documents that purportedly detail side effects caused by the Risperdal antipsychotic, but cannot be released publicly due to a court order. The documents were sealed by a Philadelphia judge as part of ongoing litigation over claims the Johnson […]
